Can chronic increased intracranial pressure or exposure to repetitive intermittent intracranial pressure elevations raise your risk for Alzheimer's disease?

Medical Hypotheses

Volumn 62, Issue 6, 2004, Pages 925-930

  Wostyn, P ^a,b  

^a PC Sint Amandus   (Belgium)

^b NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BIOACCUMULATION; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PRESSURE; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DOWN REGULATION; GLAUCOMA; HUMAN; HYPOTHESIS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; NEUROPATHOLOGY; NORMOTENSIVE HYDROCEPHALUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION; UPREGULATION; VALIDATION PROCESS;

EID: 2542475282     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.01.013     Document Type: Article

References (31)

1. Wostyn P. Intracranial pressure and Alzheimer's disease: a hypothesis. Med Hypotheses 1994;43:219-22.
2. Silverberg GD, Levinthal E, Sullivan EV, et al. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 2002;59:1139-45.
3. Salmon JH. Senile and presenile dementia: ventriculoatrial shunt for symptomatic treatment. Geriatrics 1969;24:67-72.
4. Sahuquillo J, Rubio E, Codina A, et al. Reappraisal of the intracranial pressure and cerebrospinal fluid dynamics in patients with the So-called "Normal Pressure Hydrocephalus" Syndrome. Acta Neurochir (Wien) 1991;112:50-61.
5. Bech RA, Waldemar G, Gjerris F, Klinken L, Juhler M. Shunting effects in patients with idiopathic normal pressure hydrocephalus;correlation with cerebral and leptomeningeal biopsy findings. Acta Neurochir (Wien) 1999;141:633-9.
6. Savolainen S, Paljärvi L, Vapalahti M. Prevalence of Alzheimer's disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study. Acta Neurochir (Wien) 1999;141:849-53.
7. Golomb J, Wisoff J, Miller DC, et al. Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatr 2000;68:778-81.
8. Serot JM, Bene MC, Faure GC. Normal-pressure hydrocephalus and Alzheimer disease. J Neurosurg 2003;99:797-8, author reply 798-799.
9. Silverberg GD, Huhn S, Jaffe RA, et al. Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. J Neurosurg 2002;97:1271-5.
10. Silverberg GD, Heit G, Huhn S, et al. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology 2001;57:1763-6.
11. Hochwald GM, Sahar A. Effect of spinal fluid pressure on cerebrospinal fluid formation. Exp Neurol 1971;32:30-40.
12. Madhavi C, Jacob M. Light & electron microscopic structure of choroid plexus in hydrocephalic guinea pig. Indian J Med Res 1995;101:217-24.
13. Jellinger K. Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics. Acta Neurol Belg 1976;76:83-102.
14. Serot JM, Bene MC, Foliguet B, Faure GC. Morphological alterations of the choroid plexus in late-onset Alzheimer's disease. Acta Neuropathol 2000;99:105-8.
15. Greenfield Jr JC, Rembert JC, Tindall GT. Transient changes in cerebral vascular resistance during the Valsalva maneuver in man. Stroke 1984;15:76-9.
16. Dickerman RD, Smith GH, Langham-Roof L, McConathy WJ, East JW, Smith AB. Intra-ocular pressure changes during maximal isometric contraction: does this reflect intracranial pressure or retinal venous pressure? Neurol Res 1999;21:243-6.
17. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci 2003;8:1140-56.
18. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al. Caspase Activation and Amyloid Precursor Protein Cleavage in Rat Ocular Hypertension. Invest Ophthalmol Vis Sci 2002;43:1077-87.
19. Gervais FG, Xu D, Robertson GS, et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999;97:395-406.
20. Schuman JS, Massicotte EC, Connolly S, Hertzmark E, Mukherji B, Kunen MZ. Increased intraocular pressure and visual field defects in high resistance wind instrument players. Ophthalmology 2000;107:127-33.
21. Brayne C, Calloway P. Normal ageing, impaired cognitive function, and senile dementia of the Alzheimer's type: a continuum? Lancet 1988;1(8597):1265-7.
22. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med 1980;303:130-5.
23. Gilland O, Tourtellotte WW, O'Tauma L, Henderson WG. Normal cerebrospinal fluid pressure. J Neurosurg 1974;40:587-93.
24. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-79.
25. Serot JM, Bene MC, Faure GC. Choroid plexus, ageing of the brain, and Alzheimer's disease. Front Biosci 2003;8:515-21.
26. May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI. Cerebrospinal fluid production is reduced in healthy aging. Neurology 1990;40:500-3.
27. Carskadon MA, Dement WC. Respiration during sleep in the aged human. J Gerontol 1981;36:420-3.
28. Godin O. Le mal de tête. Acta Psychiatr Belg 1976;76:209-97.
29. Van Crevel H. Pathogenesis of raised cerebrospinal fluid pressure. Doc Ophthalmol 1982;52:251-7.
30. Bosschaert MAR, Den Boer JA. Het slaap apneu syndroom in de pyschiatrie. Tijdschr Psychiatr 1992;34:525-37.
31. Jennum P, Borgesen SE. Intracranial pressure and obstructive sleep apnea. Chest 1989;95:279-83.